Is Sanofi (SNY) One of the Best Affordable Blue Chip Stocks to Buy Now?

Sanofi (NASDAQ:SNY) is included among the 10 Best Affordable Blue Chip Stocks to Buy Now.

Is Sanofi (SNY) One of the Best Affordable Blue Chip Stocks to Buy Now?

Sanofi (NASDAQ:SNY) is a healthcare biopharmaceutical company that engages in the research, development, manufacture, and marketing of therapeutic solutions.

On April 13, Citi analyst Graham Parry raised the firm’s price target on Sanofi (NASDAQ:SNY) from €80 to €82, while maintaining a ‘Neutral’ rating on the shares.

Sanofi (NASDAQ:SNY) is targeting sales to grow by a high single-digit percentage in FY 2026, with business EPS surging slightly faster than sales. The company expects this profitable growth to continue for at least five years. Moreover, Sanofi plans to execute a share buyback program of €1B this year.

The strong guidance comes despite Sanofi (NASDAQ:SNY) undergoing a significant leadership change this month, with Belén Garijo taking charge as the company’s new chief executive officer on April 29.

With an impressive annual dividend yield of 5.04%, Sanofi (NASDAQ:SNY) was recently included in our list of the 15 Large-cap Stocks with Highest Dividends.

While we acknowledge the risk and potential of SNY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SNY and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Most Undervalued Natural Gas Stocks to Buy Now and 15 Best Blue Chip Stocks to Buy Now

Disclosure: None. Follow Insider Monkey on Google News.